(Q31137269)

29 June 2017

0 references

1 reference

title

Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data (English)

1 reference

29 June 2017

1 reference

1 reference

1 reference

1 reference

1 reference

7

Renzo Guerrini

1 reference

29 June 2017

Behrouz Kassaï

1

1 reference

29 June 2017

Catherine Chiron

2

1 reference

29 June 2017

Ségolène Augier

3

1 reference

29 June 2017

Michel Cucherat

4

1 reference

29 June 2017

Elisabeth Rey

5

1 reference

29 June 2017

François Gueyffier

6

1 reference

29 June 2017

Julien Vincent

8

1 reference

29 June 2017

Olivier Dulac

9

1 reference

29 June 2017

Gérard Pons

10

1 reference

29 June 2017

publication date

19 November 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

49

1 reference

29 June 2017

issue

2

1 reference

29 June 2017

page(s)

343-348

1 reference

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Clinical trials in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Ketogenic diet in patients with Dravet syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Panniculitis due to potassium bromide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Efficacy and safety of topiramate in infants according to epilepsy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Carbamazepine-exacerbated epilepsy in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Epidemiology of Severe Myoclonic Epilepsy of Infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Comparison of evidence of treatment effects in randomized and nonrandomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Topiramate: efficacy and tolerability in children according to epilepsy syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Stiripentol, a putative antiepileptic drug, enhances the duration of opening of GABA-A receptor channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Efficacy of five days' barbiturate anesthesia in the treatment of intractable epilepsies in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

Individual response to treatment: is it a valid assumption?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01423.X

10.1111/J.1528-1167.2007.01423.X

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference